DocuSign, Inc. (NASDAQ:DOCU) Stock Holdings Lessened by Ameritas Advisory Services LLC

Ameritas Advisory Services LLC lowered its stake in DocuSign, Inc. (NASDAQ:DOCU) by 11.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 22,827 shares of the company’s stock after selling 2,904 shares during the period. Ameritas Advisory Services LLC’s holdings in DocuSign were worth $1,221,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the stock. Coatue Management LLC acquired a new stake in DocuSign during the 4th quarter valued at $288,274,000. Jericho Capital Asset Management L.P. raised its stake in DocuSign by 316.6% during the 1st quarter. Jericho Capital Asset Management L.P. now owns 3,417,908 shares of the company’s stock valued at $203,536,000 after purchasing an additional 2,597,489 shares during the period. Norges Bank purchased a new position in shares of DocuSign during the 4th quarter valued at $133,826,000. Assenagon Asset Management S.A. grew its holdings in shares of DocuSign by 956.3% during the 1st quarter. Assenagon Asset Management S.A. now owns 495,126 shares of the company’s stock valued at $29,485,000 after acquiring an additional 448,253 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of DocuSign by 2.0% during the 4th quarter. Vanguard Group Inc. now owns 21,399,739 shares of the company’s stock valued at $1,272,214,000 after acquiring an additional 417,352 shares in the last quarter. Institutional investors own 77.64% of the company’s stock.

Insider Activity

In other news, Director Teresa Briggs sold 499 shares of the stock in a transaction that occurred on Friday, May 31st. The shares were sold at an average price of $54.92, for a total transaction of $27,405.08. Following the sale, the director now directly owns 6,668 shares of the company’s stock, valued at $366,206.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Teresa Briggs sold 499 shares of the stock in a transaction that occurred on Friday, May 31st. The shares were sold at an average price of $54.92, for a total transaction of $27,405.08. Following the sale, the director now directly owns 6,668 shares of the company’s stock, valued at $366,206.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider James P. Shaughnessy sold 1,800 shares of the firm’s stock in a transaction that occurred on Tuesday, June 11th. The shares were sold at an average price of $50.98, for a total transaction of $91,764.00. Following the completion of the transaction, the insider now directly owns 35,703 shares in the company, valued at $1,820,138.94. The disclosure for this sale can be found here. Insiders have sold 475,192 shares of company stock valued at $25,095,034 over the last three months. 1.66% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Bank of America lowered their price target on shares of DocuSign from $72.00 to $60.00 and set a “neutral” rating on the stock in a report on Friday, June 7th. Morgan Stanley lowered their price target on shares of DocuSign from $65.00 to $62.00 and set an “equal weight” rating on the stock in a report on Friday, June 7th. Citigroup lowered their price target on shares of DocuSign from $93.00 to $86.00 and set a “buy” rating on the stock in a report on Wednesday, June 5th. Royal Bank of Canada decreased their price objective on shares of DocuSign from $59.00 to $52.00 and set a “sector perform” rating for the company in a report on Friday, June 7th. Finally, Piper Sandler decreased their price objective on shares of DocuSign from $65.00 to $60.00 and set a “neutral” rating for the company in a report on Friday, June 7th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $59.36.

DocuSign Stock Performance

Shares of DOCU traded up $1.37 during trading hours on Thursday, reaching $59.03. 1,619,396 shares of the company traded hands, compared to its average volume of 2,643,090. The stock’s fifty day moving average is $54.71 and its 200 day moving average is $55.55. The stock has a market cap of $12.08 billion, a P/E ratio of 113.52, a price-to-earnings-growth ratio of 8.34 and a beta of 0.94. DocuSign, Inc. has a 1-year low of $38.11 and a 1-year high of $64.76.

DocuSign (NASDAQ:DOCU) last issued its quarterly earnings data on Thursday, June 6th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.09. The firm had revenue of $709.64 million for the quarter, compared to analysts’ expectations of $706.07 million. DocuSign had a net margin of 3.81% and a return on equity of 15.44%. On average, equities research analysts predict that DocuSign, Inc. will post 0.88 EPS for the current year.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.